Biopsy verification technology developer Strand Diagnostics had raised $7.5m of a commitment from Nantworks originally slated to reach $30m.

Laboratory network operator P4 Diagnostix has paid an undisclosed amount for the assets of Strand Diagnostics, a US-based DNA testing services provider backed by diversified technology development group NantWorks. Formed in 2012 through the merger of Strand Analytical Laboratories and Diagnostic ID, Strand Diagnostics has created a technology system that relies on barcoding to verify…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.